| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| A0A0A0MS15 (HV349_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin heavy variable 3-49; | |
| P01706 (LV211_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin lambda variable 2-11; Ig gamma lambda chain V-II region DOT; Ig lambda chain V-II region BOH; Ig lambda chain V-II region BUR; Ig lambda chain V-II region NIG-58; Ig lambda chain V-II region TRO; Ig lambda chain V-II region WIN; | |
| A0A0B4J1V6 (HV373_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin heavy variable 3-73; | |
| A0A0B4J1V0 (HV315_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin heavy variable 3-15; | |
| P17027 (ZNF23_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 23; Zinc finger protein 359; Zinc finger protein 612; Zinc finger protein KOX16; | |
| A0A0C4DH43 (HV70D_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin heavy variable 2-70D; | |
| A0A075B6L2 (TVG11_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Probable non-functional T cell receptor gamma variable 11; | |
| P01817 (HV205_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin heavy variable 2-5; Ig heavy chain V-II region HE; Ig heavy chain V-II region MCE; | |
| A0A0C4DH55 (KVD07_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin kappa variable 3D-7; | |
| P04437 (TVA29_HUMAN) | Swiss-Prot | Homo sapiens (Human) | T cell receptor alpha variable 29/delta variable 5; | |
| A0A075B6H9 (LV469_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin lambda variable 4-69; | |
| Q96IX9 (A26L1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Putative ankyrin repeat domain-containing protein 26-like 1; Ankyrin repeat domain-containing protein 36B pseudogene 1; | |
| Q8TD91 (MAGC3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Melanoma-associated antigen C3; Cancer/testis antigen 7.2; Hepatocellular carcinoma-associated antigen 2; MAGE-C3 antigen; | |
| O43805 (SSNA1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Microtubule nucleation factor SSNA1; Nuclear autoantigen of 14 kDa; Sjoegren syndrome nuclear autoantigen 1; | |
| Q9NWL6 (ASND1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Asparagine synthetase domain-containing protein 1; HCV NS3-transactivated protein 1; | |
| Q92959 (SO2A1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Solute carrier organic anion transporter family member 2A1; OATP2A1; PHOAR2; Prostaglandin transporter; Solute carrier family 21 member 2; | |
| Q8TC92 (ENOX1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ecto-NOX disulfide-thiol exchanger 1; Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase; Cell proliferation-inducing gene 38 protein; Constitutive Ecto-NOX; Hydroquinone [NADH] oxidase; 1.-.-.-; Protein disulfide-thiol oxidoreductase; 1.-.-.-; | |
| A0A0B4J1Y9 (HV372_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin heavy variable 3-72; | |
| A0A0B4J1V2 (HV226_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin heavy variable 2-26; | |
| P17066 (HSP76_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Heat shock 70 kDa protein 6; Heat shock 70 kDa protein B'; Heat shock protein family A member 6; | |
| Q8NG27 (PJA1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | E3 ubiquitin-protein ligase Praja-1; RING finger protein 70; RING-type E3 ubiquitin transferase Praja-1; | |
| Q0P6H9 (TMM62_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transmembrane protein 62; | |
| Q13614 (MTMR2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR2; Myotubularin-related protein 2; Phosphatidylinositol-3-phosphate phosphatase; | |
| O95298 (NDUC2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | NADH dehydrogenase [ubiquinone] 1 subunit C2; Complex I-B14.5b; Human lung cancer oncogene 1 protein; NADH-ubiquinone oxidoreductase subunit B14.5b; | |
| Q92911 (SC5A5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Sodium/iodide cotransporter; Natrium iodide transporter; Sodium-iodide symporter; Solute carrier family 5 member 5; | |
| Q9UKV5 (AMFR_HUMAN) | Swiss-Prot | Homo sapiens (Human) | E3 ubiquitin-protein ligase AMFR; Autocrine motility factor receptor; RING finger protein 45; gp78; | |
| P60866 (RS20_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Small ribosomal subunit protein uS10; 40S ribosomal protein S20; | |
| P62314 (SMD1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Small nuclear ribonucleoprotein Sm D1; Sm-D autoantigen; snRNP core protein D1; | |
| Q6P1M0 (S27A4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Long-chain fatty acid transport protein 4; Arachidonate--CoA ligase; Long-chain-fatty-acid--CoA ligase; Solute carrier family 27 member 4; Very long-chain acyl-CoA synthetase 4; | |
| Q96QA6 (YPEL2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein yippee-like 2; | |
| A0A0A0MS01 (TVG10_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Probable non-functional T cell receptor gamma variable 10; | |
| P61236 (YPEL3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein yippee-like 3; | |
| Q96GE5 (ZN799_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 799; Zinc finger protein 842; | |
| Q96AE4 (FUBP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Far upstream element-binding protein 1; DNA helicase V; | |
| Q9P0U3 (SENP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Sentrin-specific protease 1; Sentrin/SUMO-specific protease SENP1; | |
| Q14166 (TTL12_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Tubulin--tyrosine ligase-like protein 12; Inactive tubulin--tyrosine ligase-like protein 12; | |
| Q9NRR6 (INP5E_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Phosphatidylinositol polyphosphate 5-phosphatase type IV; 72 kDa inositol polyphosphate 5-phosphatase; Inositol polyphosphate-5-phosphatase E; Phosphatidylinositol 4,5-bisphosphate 5-phosphatase; Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase; | |
| P01042 (KNG1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Kininogen-1; Alpha-2-thiol proteinase inhibitor; Fitzgerald factor; High molecular weight kininogen; Williams-Fitzgerald-Flaujeac factor; Kininogen-1 heavy chain; T-kinin; Ile-Ser-Bradykinin; Bradykinin; Kallidin I; Lysyl-bradykinin; Kallidin II; Kininogen-1 light chain; Low molecular weight growth-promoting factor; | |
| Q16587 (ZNF74_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 74; Zinc finger protein 520; hZNF7; | |
| Q3ZCX4 (ZN568_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 568; | |
| Q6NUN9 (ZN746_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 746; Parkin-interacting substrate; | |
| Q9HC58 (NCKX3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Sodium/potassium/calcium exchanger 3; Na(+)/K(+)/Ca(2+)-exchange protein 3; Solute carrier family 24 member 3; | |
| P42331 (RHG25_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Rho GTPase-activating protein 25; Rho-type GTPase-activating protein 25; | |
| Q8N239 (KLH34_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Kelch-like protein 34; | |
| Q8NG66 (NEK11_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Serine/threonine-protein kinase Nek11; Never in mitosis A-related kinase 11; | |
| Q8NA70 (FA47B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein FAM47B; | |
| Q13310 (PABP4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Polyadenylate-binding protein 4; Activated-platelet protein 1; Inducible poly(A)-binding protein; | |
| Q9Y5R2 (MMP24_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Matrix metalloproteinase-24; Membrane-type matrix metalloproteinase 5; Membrane-type-5 matrix metalloproteinase; Processed matrix metalloproteinase-24; | |
| Q8IVB4 (SL9A9_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Sodium/hydrogen exchanger 9; Na(+)/H(+) exchanger 9; Solute carrier family 9 member 9; | |
| Q8IWZ8 (SUGP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | SURP and G-patch domain-containing protein 1; RNA-binding protein RBP; Splicing factor 4; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2025_04 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 20,659 | 17,688 | 42,819 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 15-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 32-mer | 33-mer | 36-mer | 39-mer | 40-mer | 44-mer | 46-mer | 48-mer | 51-mer | 56-mer | 60-mer | 62-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38,194 | 3,274 | 316 | 612 | 58 | 127 | 16 | 54 | 2 | 18 | 8 | 43 | 1 | 4 | 2 | 22 | 10 | 1 | 1 | 2 | 15 | 2 | 1 | 3 | 1 | 2 | 1 | 7 | 1 | 1 | 4 | 1 | 1 | 12 | 2 |
